EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Peptide Drugs for Photopharmacology: How Much of a Safety Advantage Can Be Gained By Photocontrol?

Oleg Babii, Sergii Afonin, Tim Schober, Liudmyla V Garmanchuk, Liudmyla I Ostapchenko, Volodymyr Yurchenko, Sergey Zozulya, Oleksandr Tarasov, Iryna Pishel, Anne S Ulrich, Igor V Komarov

Future Drug Discovery · 2020

DOI: 10.4155/fdd-2019-0033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Future Drug Discovery, 2020. Verfasst von Oleg Babii und 10 weiteren Autor:innen. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Babii, O., Afonin, S., Schober, T., Garmanchuk, L. V., Ostapchenko, L. I., Yurchenko, V., Zozulya, S., Tarasov, O., Pishel, I., Ulrich, A. S., & Komarov, I. V. (2020). Peptide Drugs for Photopharmacology: How Much of a Safety Advantage Can Be Gained By Photocontrol?. Future Drug Discovery. https://doi.org/10.4155/fdd-2019-0033

Vancouver

Babii O, Afonin S, Schober T, Garmanchuk LV, Ostapchenko LI, Yurchenko V, et al. Peptide Drugs for Photopharmacology: How Much of a Safety Advantage Can Be Gained By Photocontrol?. Future Drug Discovery. 2020. doi:10.4155/fdd-2019-0033

BibTeX
@article{Babii2020,
  author = {Babii, Oleg and Afonin, Sergii and Schober, Tim and Garmanchuk, Liudmyla V and Ostapchenko, Liudmyla I and Yurchenko, Volodymyr and Zozulya, Sergey and Tarasov, Oleksandr and Pishel, Iryna and Ulrich, Anne S and Komarov, Igor V},
  title = {Peptide Drugs for Photopharmacology: How Much of a Safety Advantage Can Be Gained By Photocontrol?},
  journal = {Future Drug Discovery},
  year = {2020},
  doi = {10.4155/fdd-2019-0033}
}
Kostenlos starten →